Skip to main content
. Author manuscript; available in PMC: 2014 Dec 15.
Published in final edited form as: Cell Rep. 2014 Sep 18;8(6):1677–1685. doi: 10.1016/j.celrep.2014.08.039

Figure 2. Primitive neuroectodermal tumors (PNETs) derived from human iPS cells respond to OmomycER activation in vivo.

Figure 2

A, Magnetic resonance imaging (MRI) of vector control (Control) and OmomycER expressing PNETs before tamoxifen treatment and at the indicates times after treatment; B, Tumor size measured as pixel counts on MRI images of control and OmomycER PNETs; C, Histology and indicated immunohistochemical stains on control and OmomycER PNETs after tamoxifen; D, Immunfluorescence stains for Ki67 and SOX2/Nestin on OmomycER and control PNETs after treatment.